Literature DB >> 20225395

Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischaemic heart disease: is there an algorithm?

M K Poulsen1, J E Henriksen, W Vach, J Dahl, J E Møller, A Johansen, O Gerke, T Haghfelt, P F Høilund-Carlsen, H Beck-Nielsen.   

Abstract

AIMS/HYPOTHESIS: The leading cause of death in type 2 diabetes is cardiovascular disease (CVD). We examined the prevalence of myocardial ischaemia in type 2 diabetes patients and tried to establish an algorithm to identify patients with a high risk of ischaemic heart disease.
METHODS: Type 2 diabetes patients who had no known or suspected CVD, and had been referred consecutively to a diabetes clinic for the first time (n=305; age 58.6+/-11.3 years; diabetes duration 4.5+/-5.3 years) were screened for myocardial ischaemia using myocardial perfusion scintigraphy (MPS).
RESULTS: The univariate predictors of myocardial ischaemia were: atypical or typical angina pectoris, two or more traditional risk factors for CVD, BMI >32 kg/m2, systolic blood pressure >140 mmHg, HbA1c >8.5%, high-sensitivity C-reactive protein >4.0 mg/l, N-terminal pro-brain natriuretic peptide >300 pg/ml, left atrial volume index >32 ml/m2, left ventricular ejection fraction <50%, and carotid and peripheral arterial disease. The algorithm identified low (n=96), intermediate (n=65) and high risk groups (n=115), in which the prevalence of myocardial ischaemia was 15%,23% and 43%, respectively. Overall the algorithm reduced the number of patients referred to MPS from 305 to 144.However, the sensitivity and specificity of the algorithm was just 68% and 62%, respectively. CONCLUSIONS/
INTERPRETATION: Our algorithm was able to stratify which patients had a low, intermediate or high risk of myocardial ischaemia based on MPS. However, the algorithm had low sensitivity and specificity, combined with high cost and time requirements. TRIAL REGISTRATION: clinicaltrials.gov NCT00298844 FUNDING: The study was funded by the Danish Cardio vascular Research Academy (DaCRA), The Danish Diabetes Association and The Danish Heart Foundation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225395     DOI: 10.1007/s00125-009-1646-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?

Authors:  E Cosson; F Paycha; J Paries; S Cattan; A Ramadan; D Meddah; J-R Attali; P Valensi
Journal:  Diabet Med       Date:  2004-04       Impact factor: 4.359

2.  Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  L E Chambless; A R Folsom; L X Clegg; A R Sharrett; E Shahar; F J Nieto; W D Rosamond; G Evans
Journal:  Am J Epidemiol       Date:  2000-03-01       Impact factor: 4.897

3.  Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France.

Authors:  A Sultan; C Piot; D Mariano-Goulart; J P Daures; F Comte; E Renard; A Avignon
Journal:  Diabet Med       Date:  2006-04       Impact factor: 4.359

4.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.

Authors:  L E Chambless; G Heiss; A R Folsom; W Rosamond; M Szklo; A R Sharrett; L X Clegg
Journal:  Am J Epidemiol       Date:  1997-09-15       Impact factor: 4.897

5.  Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group.

Authors: 
Journal:  Am J Cardiol       Date:  1997-01-15       Impact factor: 2.778

6.  Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.

Authors:  G Vanzetto; S Halimi; T Hammoud; D Fagret; P Y Benhamou; D Cordonnier; B Denis; J Machecourt
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

7.  Silent myocardial ischemia in patients with diabetes: who to screen.

Authors:  B Janand-Delenne; B Savin; G Habib; M Bory; P Vague; V Lassmann-Vague
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism.

Authors:  Carmine Gazzaruso; Adriana Garzaniti; Stefano Giordanetti; Colomba Falcone; Emanuela De Amici; Diego Geroldi; Pietro Fratino
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

9.  B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  R Li; B B Duncan; P A Metcalf; J R Crouse; A R Sharrett; H A Tyroler; R Barnes; G Heiss
Journal:  Stroke       Date:  1994-12       Impact factor: 7.914

10.  Ultrasonographically assessed carotid morphology and the risk of coronary heart disease.

Authors:  J T Salonen; R Salonen
Journal:  Arterioscler Thromb       Date:  1991 Sep-Oct
View more
  3 in total

1.  Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Cinzia Valenti; Gabriele Pelissero; Sebastiano Bruno Solerte; Fabrizio Salvucci; Pietro Gallotti; Arturo Pujia; Adriana Garzaniti; Andrea Giustina
Journal:  Intern Emerg Med       Date:  2011-02-05       Impact factor: 3.397

2.  Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.

Authors:  Piercarlo Ballo; Irene Betti; Alessandro Barchielli; Daniela Balzi; Gabriele Castelli; Leonardo De Luca; Mihai Gheorghiade; Alfredo Zuppiroli
Journal:  Clin Res Cardiol       Date:  2015-11-07       Impact factor: 5.460

3.  Myocardial perfusion abnormalities in asymptomatic type 2 diabetic patients.

Authors:  Ghada Al-Humaidi; Ismet Sarikaya; Abdelhamid H Elgazzar; Azu Owunwanne
Journal:  J Saudi Heart Assoc       Date:  2017-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.